KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Ginkgo Bioworks Holdings (DNA) Leases (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Leases readings, the most recent being $360.9 million for Q4 2025.

  • On a quarterly basis, Leases fell 8.5% to $360.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $360.9 million, a 8.5% decrease, with the full-year FY2025 number at $360.9 million, down 8.5% from a year prior.
  • Leases hit $360.9 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $368.2 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $418.0 million in Q2 2024 to a low of $4.1 million in Q4 2021.
  • Median Leases over the past 5 years was $379.6 million (2025), compared with a mean of $332.9 million.
  • Biggest five-year swings in Leases: soared 9674.68% in 2022 and later tumbled 48.4% in 2023.
  • Ginkgo Bioworks Holdings' Leases stood at $4.1 million in 2021, then soared by 9674.68% to $400.8 million in 2022, then crashed by 48.4% to $206.8 million in 2023, then skyrocketed by 90.73% to $394.4 million in 2024, then fell by 8.5% to $360.9 million in 2025.
  • The last three reported values for Leases were $360.9 million (Q4 2025), $368.2 million (Q3 2025), and $375.8 million (Q2 2025) per Business Quant data.